DealPredicta Biosciences, a Cambridge, Massachusetts-based diagnostic and analytics platform for blood cancers and autoimmune diseases, raised $23.4 million in a Series A fundraising round led by Engine Ventures with participation from Illumina Ventures, Lightchain Capital, and others.
More on VC News Daily →
SERIES A
10/03/2025
Verismo Therapeutics, Inc., a Philadelphia, PA-based CAR-T cell therapy...
Yoga Joint, a Fort Lauderdale, FL-based hot yoga studio chain, raised $5.5...
Timeshifter, a New York-based circadian tech for jet lag, raised an...
Osteoboost Health, a Redwood City, CA-based FDA-cleared bone health...
Clean Slate Clinic, a Sydney-based virtual alcohol detox platform, raised...
Reme-D, a Cairo-based room-temperature PCR test kits company, raised...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
